Cresco Labs Inc
CL.CD- Latest Trade
- trading higher2.45CAD
- 0.14
- 6.06%
- As of Feb 1 2023. Values delayed up to 15 minutes
- Day Range
- 2.34 - 2.85
- 52-Week Range
- 2.20 - 10.36
- Previous Close
- 2.31
- Open
- 2.40
- Volume
- 535,736.00
- 3 Month Average Trading Volume
- 8.28
- Shares Out (Mil)
- 407.66
- Market Cap
- 652.74
- Forward P/E
- -15.22
- Dividend Yield
- 0.00
Key Statistics
1.84210526 mean rating - 19 analysts
- P/E Excl. Extra Items (TTM)
- 0.00
- Price To Sales (TTM)
- 0.57
- Price To Book (Quarterly)
- 0.90
- Price To Cash Flow (Per Share TTM)
- 142.73
- Total Debt/Total Equity (Quarterly)
- 85.73
- Long Term Debt/Equity (Quarterly)
- 79.34
- Return On Investment (TTM)
- -3.34
- Return On Equity (TTM)
- -2.83
2021 (millions USD)
About Cresco Labs Inc (CL.CD)
Company Information
Cresco Labs Inc. is an integrated multi-state cannabis operator in the United States. The Company is the wholesaler of branded cannabis products. The Company is licensed to cultivate, manufacture, and sell retail and medical cannabis products primarily through Sunnyside, Cresco Labs’ national dispensary brand, and third-party retail stores. Its family brands include Cresco, Reserve, High Supply, Good News, Wonder Wellness Co., FloraCal Farms, Remedi and Mindy’s. Its portfolio consists of over 300 products. Its products are sold in over 1,200 dispensaries across the country. It has an ownership interest in approximately 10 operational dispensaries in the State of Illinois; over 10 dispensaries in the State of Pennsylvania; five dispensaries in the State of Ohio; one dispensary in the State of Arizona; four dispensaries in the State of New York; four dispensaries in the State of Massachusetts; and approximately 16 dispensaries in the state of Florida.
Address
400 W ERIE ST SUITE 110CHICAGO, IL
60654
United States
Industry
Biotechnology & Drugs
Executive Leadership
- Thomas J. Manning
- Executive Chairman of the Board
- Charles Bachtell
- Chief Executive Officer, Director
- Dennis M. Olis
- Chief Financial Officer
- Ty Gent
- Chief Operating Officer
- Zach Marburger
- Chief Information Officer
- John P. Schetz
- General Counsel
- Marc Lustig
- Director, Head of Capital Markets
- Gregory Butler
- Chief Commercial Officer
- Angie Demchenko
- Chief People Officer
- Jason Bennett Erkes
- Chief Communications Officer
- Tarik Brooks
- Independent Director
- Gerald F. Corcoran
- Independent Director
- Randy Dean Podolsky
- Independent Director
- Michele Roberts
- Independent Director
- Robert M. Sampson
- Independent Director
- Carol A. Vallone
- Independent Director
- John Robert Walter
- Independent Director
Latest News
Financials
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,926.80 | 0.14% |
| Copper | 786.60 | 0.13% |
| Brent Crude Oil | 85.78 | 0.37% |
| CBOT Soybeans | 1,537.50 | 0.03% |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,076.60 | 1.46% |
| Euro STOXX 50 | 4,163.45 | -- |
| FTSE 100 | 7,771.70 | 0.17% |
| Nikkei 225 | 27,347.02 | 0.07% |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes